You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Soluble CD25

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tregs CD25 CXCL9 in Vitiligo

Not yet recruiting
  • Vitiligo
  • +3 more
  • ELIZA , Flowcytometry
  • (no location specified)
Oct 3, 2022

Glioblastoma Trial (plasma collection)

Not yet recruiting
  • Glioblastoma
  • plasma collection
  • (no location specified)
Aug 18, 2023

The Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT Trial (CD25

Not yet recruiting
  • The Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT
  • CD25 prophylaxis
  • (no location specified)
Jun 20, 2023

ANCA Associated Vasculitis Trial in Bordeaux (blood sample, urine sample)

Recruiting
  • ANCA Associated Vasculitis
  • blood sample
  • urine sample
  • Bordeaux, France
    CHU de Bordeaux - Service d'Immunologie et Immunogénétique
Dec 13, 2022

Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Sep 27, 2023

Pathophysiology of Non-infectious Active Uveitis

Recruiting
  • Non-Infectious Active Uveitis
  • s-CD95-L
  • Bordeaux, France
    CHU Bordeaux
Apr 11, 2022

Health Status of Children Born After Assisted Reproductive

Recruiting
  • Children Born After Assisted Reproductive Technologies
  • +2 more
  • hemogram examination
  • Almaty, Kazakhstan
    Sevara ilmuratova
Oct 17, 2023

sCD8, as a Novel Biomarker for Pancreatic Cancer

Recruiting
  • Serum Biomarker
  • Pancreatic Cancer
  • serum test
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 11, 2022

Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

Active, not recruiting
Has Results
  • Hairy Cell Leukemia
  • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Jan 12, 2023

Metastatic Pancreatic Adenocarcinoma Trial (odetiglucan, CDX-1140)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • odetiglucan
  • CDX-1140
  • (no location specified)
Jul 29, 2022

Liver Transplant Trial in Boston (biological, procedure, drug)

Recruiting
  • Liver Transplant
  • arTreg-CSB
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital: Transplantation
Jan 30, 2023

Interleukins in Periodontal Disease Progression

Recruiting
  • Periodontitis
  • Gingivitis
  • Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
  • Assiut, Asyut, Egypt
    Department of oral medicine, Periodontology, Oral diagnosis and
Nov 16, 2023

Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)

Completed
  • Haematological Malignancies
  • CD25/71 allodepleted donor T-cells
  • London, United Kingdom
  • +1 more
Jul 18, 2022

Late Complication From Kidney Transplant Trial in San Francisco (Treg infusion)

Completed
  • Late Complication From Kidney Transplant
  • Treg infusion
  • San Francisco, California
    University of California, San Francisco
Jul 11, 2022

Liver Transplant Trial in San Francisco (biological, procedure, drug)

Recruiting
  • Liver Transplant
  • arTreg
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Sep 13, 2022

Parkinson Disease Trial in Rome (Standard LD/CD, Semi continuous intra-oral administration of LD/CD)

Completed
  • Parkinson Disease
  • Standard LD/CD
  • Semi continuous intra-oral administration of LD/CD
  • Rome, Italy
    Irccs San Raffaele Pisana
Oct 17, 2022

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)

Recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Basiliximab
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Jun 16, 2022

Lymphoma Trial (68Ga-NOTA-RP25)

Not yet recruiting
  • Lymphoma
  • 68Ga-NOTA-RP25
  • (no location specified)
Dec 16, 2021

CD19+ Relapse/Refractory B-ALL Trial in Beijing (CAR-T-19 Cells)

Recruiting
  • CD19+ Relapse/Refractory B-ALL
  • CAR-T-19 Cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Feb 26, 2022

Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV Trial in Chapel Hill, Columbus (Cryopreserved Ex Vivo

Recruiting
  • Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV
  • Cryopreserved Ex Vivo Expanded Polyclonal CD4+CD127lo/-CD25+ T Regulatory Cells
  • Chapel Hill, North Carolina
  • +1 more
Oct 15, 2021

Type 1 Diabetes Trial in San Francisco, New Haven (PolyTregs+IL-2)

Completed
  • Type 1 Diabetes Mellitus
  • PolyTregs+IL-2
  • San Francisco, California
  • +1 more
Oct 15, 2021

Pemphigus Foliaceus, Pemphigus Vulgaris Trial in United States (Cohort 1: 1.0 x 10^8 PolyTregs, Cohort 2: 2.5x10^8 PolyTregs)

Active, not recruiting
Has Results
  • Pemphigus Foliaceus
  • Pemphigus Vulgaris
  • Cohort 1: 1.0 x 10^8 PolyTregs
  • Cohort 2: 2.5x10^8 PolyTregs
  • San Francisco, California
  • +3 more
Oct 22, 2021

Safety and Efficacy Trial in Suzhou (Ruxolitinib)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 23, 2021

Hodgkin Disease, Hodgkin Lymphoma Trial run by the NCI (procedure, drug, radiation)

Terminated
Has Results
  • Hodgkin Disease
  • Hodgkin Lymphoma
  • Auto stem cell transplant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021